{
  "directed": true,
  "graph": {
    "annotation_list": {
      "Braak_Stage": [
        "Stage I",
        "Stage II",
        "Stage III",
        "Stage IV",
        "Stage V",
        "Stage VI"
      ]
    },
    "annotation_pattern": {
      "Species": "\\d+"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Kristian Kolpeja, Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "CL": "^\\d{7}$",
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mesh-names.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns"
    },
    "path": "tau/simic2016.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Using the same tau-1 monoclonal antibody and electron microscopy with colloidal gold-labeled secondary antibodies, tau was also found in very low amounts in astrocytes [16] and oligodendrocytes [17], and this was confirmed by tau mRNA expression analysis in the mouse brain [18].",
      "key": "f1363a33262a3b4312c17ca53592e31c",
      "line": 73,
      "relation": "partOf",
      "source": 112,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Using the same tau-1 monoclonal antibody and electron microscopy with colloidal gold-labeled secondary antibodies, tau was also found in very low amounts in astrocytes [16] and oligodendrocytes [17], and this was confirmed by tau mRNA expression analysis in the mouse brain [18].",
      "key": "65d64de8f26d9f6a7ec64272eeda35cd",
      "line": 74,
      "relation": "partOf",
      "source": 112,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "bc2df1af0bf572f2ce0bc19d94c00593",
      "line": 82,
      "relation": "positiveCorrelation",
      "source": 89,
      "target": 106
    },
    {
      "key": "cdf082fe6332262197d7fa17b36854d3",
      "relation": "hasVariant",
      "source": 62,
      "target": 89
    },
    {
      "key": "19c4e7892eabb4f1a61045e262749341",
      "relation": "hasVariant",
      "source": 62,
      "target": 80
    },
    {
      "key": "97c3097784ab44c2d5d228b9fca3f4db",
      "relation": "hasVariant",
      "source": 62,
      "target": 87
    },
    {
      "key": "8738e652e0db5aa1beae0696f65c9838",
      "relation": "hasVariant",
      "source": 62,
      "target": 88
    },
    {
      "key": "1132470edf80aa28d2846bbaeae75a51",
      "relation": "hasVariant",
      "source": 62,
      "target": 64
    },
    {
      "key": "f493f0fee738226075e2a2bb020e3182",
      "relation": "hasVariant",
      "source": 62,
      "target": 81
    },
    {
      "key": "e6e028a889cebf1d578a2febbb286fc8",
      "relation": "hasVariant",
      "source": 62,
      "target": 82
    },
    {
      "key": "c4f977af252bb318cb0ba1221781fcff",
      "relation": "hasVariant",
      "source": 62,
      "target": 83
    },
    {
      "key": "dad505acb6828a236dfb9020eba1c1fd",
      "relation": "hasVariant",
      "source": 62,
      "target": 84
    },
    {
      "key": "73ed6e5d102a697878754c0eb14d9d75",
      "relation": "hasVariant",
      "source": 62,
      "target": 65
    },
    {
      "key": "2b71969d91154649848046d39d38683d",
      "relation": "hasVariant",
      "source": 62,
      "target": 66
    },
    {
      "key": "a9689aa2fd4466ac785294ce2909ee46",
      "relation": "hasVariant",
      "source": 62,
      "target": 90
    },
    {
      "key": "78e8b51ec25bf762a9231ad81e1b87c1",
      "relation": "hasVariant",
      "source": 62,
      "target": 67
    },
    {
      "key": "358278135ae70ee5775565e96e44da64",
      "relation": "hasVariant",
      "source": 62,
      "target": 68
    },
    {
      "key": "a10680e68dbec5aebf32be45eac6c383",
      "relation": "hasVariant",
      "source": 62,
      "target": 69
    },
    {
      "key": "65b09e34b952efff463573f6515d5ea1",
      "relation": "hasVariant",
      "source": 62,
      "target": 70
    },
    {
      "key": "87361d44bedd002f6017ec0cbaf396fc",
      "relation": "hasVariant",
      "source": 62,
      "target": 71
    },
    {
      "key": "0ded58a335dd7733a4ee21ed119f0f41",
      "relation": "hasVariant",
      "source": 62,
      "target": 72
    },
    {
      "key": "66a0ff7d5f221b0d68cbc5dbafef81f5",
      "relation": "hasVariant",
      "source": 62,
      "target": 73
    },
    {
      "key": "23aecbb223f3afcc6531f2eaec740ae3",
      "relation": "hasVariant",
      "source": 62,
      "target": 74
    },
    {
      "key": "55a0cc9e48187fc8d6cfd504159557bb",
      "relation": "hasVariant",
      "source": 62,
      "target": 75
    },
    {
      "key": "4a8d87e120d2f1a1f4b2baf5a5a4677a",
      "relation": "hasVariant",
      "source": 62,
      "target": 91
    },
    {
      "key": "9bb8da6adb9851ede22fff997b42c6c2",
      "relation": "hasVariant",
      "source": 62,
      "target": 85
    },
    {
      "key": "5fcacfdef648f5963fd8f7d8cece26aa",
      "relation": "hasVariant",
      "source": 62,
      "target": 76
    },
    {
      "key": "3e9b380e030caf4e93ffed80783e9261",
      "relation": "hasVariant",
      "source": 62,
      "target": 79
    },
    {
      "key": "cce048e5d3269e415bf6bf4c127b68ca",
      "relation": "hasVariant",
      "source": 62,
      "target": 86
    },
    {
      "key": "089275fc41c4bec44c9ca3c31908d8d1",
      "relation": "hasVariant",
      "source": 62,
      "target": 78
    },
    {
      "key": "0b23e783b6df6bf81703fab83a2f8726",
      "relation": "hasVariant",
      "source": 62,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "An additional “knot” of tau being entangled in epigenetic landscape of neurodegeneration comes from the finding that by acting as a HDAC6 inhibitor, tau is being indirectly involved in both (dys)regulation of transcriptional activity and impairment of autophagic clearance by the ubiquitin proteasome system [81,82].",
      "key": "b16e8c32d483f562f7d6dc1287948f4c",
      "line": 153,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 62,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "An additional “knot” of tau being entangled in epigenetic landscape of neurodegeneration comes from the finding that by acting as a HDAC6 inhibitor, tau is being indirectly involved in both (dys)regulation of transcriptional activity and impairment of autophagic clearance by the ubiquitin proteasome system [81,82].",
      "key": "cf0fa151a7510e7547e017d0e7bc84e5",
      "line": 154,
      "relation": "regulates",
      "source": 62,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "An additional “knot” of tau being entangled in epigenetic landscape of neurodegeneration comes from the finding that by acting as a HDAC6 inhibitor, tau is being indirectly involved in both (dys)regulation of transcriptional activity and impairment of autophagic clearance by the ubiquitin proteasome system [81,82].",
      "key": "4263652eb8e4a89f01d8a8e61654ec9b",
      "line": 155,
      "relation": "decreases",
      "source": 62,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "An additional “knot” of tau being entangled in epigenetic landscape of neurodegeneration comes from the finding that by acting as a HDAC6 inhibitor, tau is being indirectly involved in both (dys)regulation of transcriptional activity and impairment of autophagic clearance by the ubiquitin proteasome system [81,82].",
      "key": "4a5859d67336cd02bbb3c29725aed850",
      "line": 156,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 62,
      "target": 40
    },
    {
      "key": "1cb345f817331216b34da4f99d0b9234",
      "relation": "hasVariant",
      "source": 62,
      "target": 95
    },
    {
      "key": "fdfa00de27024081a93534b02ff54ea7",
      "relation": "hasVariant",
      "source": 62,
      "target": 96
    },
    {
      "key": "eb1a616d7c5144d1c0408df4ce8b9deb",
      "relation": "hasVariant",
      "source": 62,
      "target": 94
    },
    {
      "key": "9a05817db0e2bf677b756eaadcac25ac",
      "relation": "hasVariant",
      "source": 62,
      "target": 92
    },
    {
      "key": "9d8aa9f793a734719537f891b64a4470",
      "relation": "hasVariant",
      "source": 62,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "7bb3f87fb485492c7385df6ca301bd52",
      "line": 232,
      "relation": "positiveCorrelation",
      "source": 62,
      "target": 31
    },
    {
      "key": "d93cd7a1c339a0fb7809f4a1b928aedd",
      "relation": "hasVariant",
      "source": 62,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "7f4fb67d56e63a9fc025b0df4bbef907",
      "line": 82,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "803edb36ea7bb7a750d350f8c404a47b",
      "line": 83,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "423542eeba9bced52c09de5a53f0bf27",
      "line": 84,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "1d1898e91c2be312fb3143cc16db1127",
      "line": 85,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "2062a1c3c1765a98174f6ebe5abd5546",
      "line": 86,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "d2194d39aeb4302421954a04b1d998ec",
      "line": 87,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "7fc6090b0a9c3a9c4a6df6ad35c68e89",
      "line": 88,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "4130f194674a7c6521a4081ede8a7b08",
      "line": 89,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "a4b3a2c892e621675e3454edba3b03dd",
      "line": 90,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "eee7da939778e376cbd636cc12d58125",
      "line": 91,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "51a6f27ae8e7de41906739d7d22d8626",
      "line": 92,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "f5586fa893d8b496bf15ab91fd899427",
      "line": 93,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "ae6e8e5ee06ead2e06b1bf95ecb70843",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "25fdc649d2ebf56da0463902291b9786",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "2b041e905c553318eaf1f20474c8211d",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "2893f75b4831e036345eb7524e12b31f",
      "line": 97,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "e97fc5b48e69da2f7f56ae1cbbbaa107",
      "line": 98,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "1c23d2c7be20b4579632362a754918ae",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "f3c6f490bf0ab213bf8433b5864244c9",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "05743a5b50c6d89711f7f233c262771c",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "e6c36a8eda4ac31b7def4cbdec127863",
      "line": 102,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "aa27b902d648589034337c5d3dca1955",
      "line": 103,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "3e8db1f6ee8b96552f07091e3c0e7cbc",
      "line": 104,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "29e42d4a9d269e28b3673a5f75dae82c",
      "line": 105,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "2881e93d9cc7bc9628762d2ae7b994a6",
      "line": 106,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "f9094246cddede6dd3688952e8078465",
      "line": 107,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "3021e5afb79ae7f533a9afcac485adac",
      "line": 108,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "2610e0ecae9713742a6f7a3332e3245b",
      "line": 109,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "e578e89370e32a5638d72ea68a92574a",
      "line": 83,
      "relation": "positiveCorrelation",
      "source": 80,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "ae44bb0a4ca131d4ced5abddd52a9b5c",
      "line": 84,
      "relation": "positiveCorrelation",
      "source": 87,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "0ffccd2fc6462fbeac6ff651af3ed192",
      "line": 85,
      "relation": "positiveCorrelation",
      "source": 88,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "7e97354e4a05dad769ced706e40fe59a",
      "line": 86,
      "relation": "positiveCorrelation",
      "source": 64,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "4451ab0c496450cf00e16968f3cba462",
      "line": 87,
      "relation": "positiveCorrelation",
      "source": 81,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "2e6a31e277ec7e0c74eb0fde00d6cf07",
      "line": 88,
      "relation": "positiveCorrelation",
      "source": 82,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "49c0fcfd1cb5b187b094c5b369aab4a0",
      "line": 89,
      "relation": "positiveCorrelation",
      "source": 83,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "368f54075fb103b8995ecfc20801f0e2",
      "line": 90,
      "relation": "positiveCorrelation",
      "source": 84,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "3a8915f87d763a2b8c0ced402c882797",
      "line": 91,
      "relation": "positiveCorrelation",
      "source": 65,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "b1f5af720be0ddb320c67516d2be5403",
      "line": 92,
      "relation": "positiveCorrelation",
      "source": 66,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "07e3bc8cafe602882207821e10021545",
      "line": 93,
      "relation": "positiveCorrelation",
      "source": 90,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "18b1e5bd5eda5c2451d76eb868c5a08d",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 67,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "288a2050dbabb5f836247fd21be03bd3",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "ab5987f0ba3f79dee8cdbe63917cf4d3",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 69,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "66fb97c40b44f131f79abe2e705fdeab",
      "line": 97,
      "relation": "positiveCorrelation",
      "source": 70,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "797120424e7019e5d21f1876aa0d403a",
      "line": 98,
      "relation": "positiveCorrelation",
      "source": 71,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "3ba871b057ee09da189fbfb95097a382",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 72,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "f2426719dbace2662646ef4cf3f31494",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 73,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "e8eb32411579166e8ecfe5de3ec44c9a",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 74,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "21646207500e2240f233a34545c4699b",
      "line": 102,
      "relation": "positiveCorrelation",
      "source": 75,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "7612a81126ea23c67bbbfdc66dcc0649",
      "line": 103,
      "relation": "positiveCorrelation",
      "source": 91,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "d11197fbd2c541808f675cf6ee857dea",
      "line": 104,
      "relation": "positiveCorrelation",
      "source": 85,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "762f6a03f9a24eb8560c4801e725f0b8",
      "line": 105,
      "relation": "positiveCorrelation",
      "source": 76,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "c93865445742a7fb05ce0fe891877ea3",
      "line": 106,
      "relation": "positiveCorrelation",
      "source": 79,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "5cb585254ca837a0f452cb410d758f92",
      "line": 107,
      "relation": "positiveCorrelation",
      "source": 86,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "a1972b3b8e2e4ecbc3fb6df832ff96be",
      "line": 108,
      "relation": "positiveCorrelation",
      "source": 78,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "3. Putative phosphorylation sites on tau protein and epitopes specific for major tau antibodies. Red color denotes amino acids phosphorylation in AD brain.",
      "key": "9e0ca25048fb663a4a0de92ded485d8a",
      "line": 109,
      "relation": "positiveCorrelation",
      "source": 77,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A quite different strategy is to target tau clearance—e.g., by rapamycin that induces macroautophagy [175], inhibitors of Hsp90 chaperone protein that binds to misfolded proteins or by immunotherapeutic approaches [176].",
      "key": "21b75d6ba421719b86038f6f7a25661d",
      "line": 262,
      "relation": "partOf",
      "source": 77,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Apart from binding to MT, the repeat domains of tau also bind to tubulin deacetylase, histone deacetylase 6 (HDAC6) [68] and apolipoprotein E (apoE) more with the 3 than the 4 isovariant [69]).",
      "key": "1f54c7900c6df5ef8ddb37cf225a8dd9",
      "line": 116,
      "relation": "association",
      "source": 49,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Apart from binding to MT, the repeat domains of tau also bind to tubulin deacetylase, histone deacetylase 6 (HDAC6) [68] and apolipoprotein E (apoE) more with the 3 than the 4 isovariant [69]).",
      "key": "3155a3b52a495bb8a639327ff37c94cb",
      "line": 120,
      "relation": "partOf",
      "source": 49,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Apart from binding to MT, the repeat domains of tau also bind to tubulin deacetylase, histone deacetylase 6 (HDAC6) [68] and apolipoprotein E (apoE) more with the 3 than the 4 isovariant [69]).",
      "key": "a997582797f494954298f4b52bc969a5",
      "line": 116,
      "relation": "association",
      "source": 60,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Apart from binding to MT, the repeat domains of tau also bind to tubulin deacetylase, histone deacetylase 6 (HDAC6) [68] and apolipoprotein E (apoE) more with the 3 than the 4 isovariant [69]).",
      "key": "df34beedee8c36b661b1f231fef1969f",
      "line": 117,
      "relation": "association",
      "source": 52,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Apart from binding to MT, the repeat domains of tau also bind to tubulin deacetylase, histone deacetylase 6 (HDAC6) [68] and apolipoprotein E (apoE) more with the 3 than the 4 isovariant [69]).",
      "key": "46bd57ffbdc4fa5c02e3895891cce660",
      "line": 119,
      "relation": "partOf",
      "source": 52,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Apart from binding to MT, the repeat domains of tau also bind to tubulin deacetylase, histone deacetylase 6 (HDAC6) [68] and apolipoprotein E (apoE) more with the 3 than the 4 isovariant [69]).",
      "key": "416e168f52e257388294421eb5689ee0",
      "line": 117,
      "relation": "association",
      "source": 42,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "af912ce7f36b73ddaf75d94ca7dddcf6",
      "line": 127,
      "relation": "association",
      "source": 51,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "1aeec20e137cd8f77bc9d693631b0f1c",
      "line": 128,
      "relation": "association",
      "source": 51,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "ed2da8a4b54966af64f6d126ad779aa8",
      "line": 129,
      "relation": "association",
      "source": 51,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "918c87a456504de96d66e997351b0fb1",
      "line": 130,
      "relation": "association",
      "source": 51,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "1711c5970f5897bce59d4539d4b706b8",
      "line": 131,
      "relation": "association",
      "source": 51,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "07316c371861e999db5d04ad5d59035a",
      "line": 132,
      "relation": "association",
      "source": 51,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "09c909b23f74a94e305aba0ea05ad4ba",
      "line": 133,
      "relation": "association",
      "source": 51,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "65506a71499610df2e486401170bb36c",
      "line": 134,
      "relation": "association",
      "source": 51,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "f750aecdfbf6085293fba7ab213c70e3",
      "line": 136,
      "relation": "partOf",
      "source": 51,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In synapses, the projection domain of tau interacts with protein kinase Fyn (plays an important role during myelination [75]), postsynaptic density protein 95 (PSD-95) [76], and N-methyl-D-aspartate receptors (NMDAR).",
      "key": "1053553f8de79969c92a4a484e53bf0a",
      "line": 143,
      "relation": "association",
      "source": 51,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In synapses, the projection domain of tau interacts with protein kinase Fyn (plays an important role during myelination [75]), postsynaptic density protein 95 (PSD-95) [76], and N-methyl-D-aspartate receptors (NMDAR).",
      "key": "40c9e1a816bf23c2cf1b310ff6d6d0cc",
      "line": 144,
      "relation": "association",
      "source": 51,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In synapses, the projection domain of tau interacts with protein kinase Fyn (plays an important role during myelination [75]), postsynaptic density protein 95 (PSD-95) [76], and N-methyl-D-aspartate receptors (NMDAR).",
      "key": "252004ef0ba6ecc6c08452414fb672ed",
      "line": 145,
      "relation": "association",
      "source": 51,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "dba15f079f33b07408fd83add2ca6c62",
      "line": 127,
      "relation": "association",
      "source": 61,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "dc842d0d8f83e965c0780325d022fb4d",
      "line": 128,
      "relation": "association",
      "source": 57,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "15e2e9705a7e89304562c04e54c90ef0",
      "line": 129,
      "relation": "association",
      "source": 102,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "57a0b0948b474c59570b7c189085c6be",
      "line": 130,
      "relation": "association",
      "source": 59,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "dbc2cce9ad9674cd212953b099f17846",
      "line": 131,
      "relation": "association",
      "source": 53,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "1804de1ebbc943ef023ab0bd9d40fe68",
      "line": 132,
      "relation": "association",
      "source": 14,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "5433e88e429c6049e9a2aa153a4d5c91",
      "line": 133,
      "relation": "association",
      "source": 4,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The projection domain of tau may be involved in cell signaling that occurs through the interaction with Lck, Fgr and cSrc (Src-family kinases), growth factor receptor-bound protein 2 (Grb2), phospholipase C- [70], phosphatidylinositol and phosphatidylinositol bisphosphate [71,72], peptidyl-prolyl cis/trans isomerase Pin 1, and many others (for review see [73]), making them potential therapeutic targets in tauopathies [74].",
      "key": "fde64306d035c246c22e9a17144fc030",
      "line": 134,
      "relation": "association",
      "source": 97,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In synapses, the projection domain of tau interacts with protein kinase Fyn (plays an important role during myelination [75]), postsynaptic density protein 95 (PSD-95) [76], and N-methyl-D-aspartate receptors (NMDAR).",
      "key": "1b71f9b69394f96a82de78cb70612ac2",
      "line": 143,
      "relation": "association",
      "source": 58,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In synapses, the projection domain of tau interacts with protein kinase Fyn (plays an important role during myelination [75]), postsynaptic density protein 95 (PSD-95) [76], and N-methyl-D-aspartate receptors (NMDAR).",
      "key": "ca879cd5f25288118dec5e9d19535bd1",
      "line": 144,
      "relation": "association",
      "source": 56,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In synapses, the projection domain of tau interacts with protein kinase Fyn (plays an important role during myelination [75]), postsynaptic density protein 95 (PSD-95) [76], and N-methyl-D-aspartate receptors (NMDAR).",
      "key": "5f2d62f509488bf535f88e1f273e5143",
      "line": 145,
      "relation": "association",
      "source": 29,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "An additional “knot” of tau being entangled in epigenetic landscape of neurodegeneration comes from the finding that by acting as a HDAC6 inhibitor, tau is being indirectly involved in both (dys)regulation of transcriptional activity and impairment of autophagic clearance by the ubiquitin proteasome system [81,82].",
      "key": "595c1d34ab6af2e568b67c0c68ab3e64",
      "line": 156,
      "relation": "negativeCorrelation",
      "source": 40,
      "subject": {
        "modifier": "Activity"
      },
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "5ff1a3ffa9591e6e6f584ab50e3f7e50",
      "line": 166,
      "relation": "positiveCorrelation",
      "source": 46,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "f6911cc6e2b4ebdfd2420e9b9967d3be",
      "line": 167,
      "relation": "positiveCorrelation",
      "source": 46,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "6928f9eddece7e3e341afc3889ae1ca5",
      "line": 168,
      "relation": "positiveCorrelation",
      "source": 46,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "6663af69ba4fc76e34ad3547dd9c6b45",
      "line": 169,
      "relation": "positiveCorrelation",
      "source": 46,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "b136595d5d4e1c47e0270fbfceabf056",
      "line": 166,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "a8562482643ea0659f65875c3ab8aabd",
      "line": 167,
      "relation": "positiveCorrelation",
      "source": 104,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "01a59aaaa9953960218f1e7cc3d47ee5",
      "line": 168,
      "relation": "positiveCorrelation",
      "source": 110,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "a9bc11cba5167b2efc41191e511e9182",
      "line": 169,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "8b3d5343377f9c0356b03bfa364f46d5",
      "line": 179,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "578743700a71db69ae909be7b62040d4",
      "line": 180,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "df695bf35fefcc7ce35e8b6fac1a1c6a",
      "line": 181,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "91c79f229d41b83d08919cd015bfd17f",
      "line": 182,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "1165297f8a35c69a00df896669cc962d",
      "line": 190,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "b54b648fbfac586440e5de8d02d8e005",
      "line": 171,
      "relation": "positiveCorrelation",
      "source": 45,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "On the other side, sarkosyl extracts from the filaments of PSP [129], corticobasal degeneration (CBD; [130]), argyrophilic grain disease (AgD; [131]), and some cases of FTDP-17, contain tau protein that separates as doublets of 64 and 69 kDa and are predominantly composed of tau isoforms with 4R (class II tauopathies), whereas sarkosyl extracts from filaments of Pick’s disease are characterized by the presence of pathological tau doublets of 60 and 64 kDa and contain mainly 3R tau isoforms (class III tauopathy).",
      "key": "315227584490cd8e140cafd94cbbc77f",
      "line": 171,
      "relation": "positiveCorrelation",
      "source": 108,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "b378939f78387aea816161690a283b69",
      "line": 191,
      "relation": "positiveCorrelation",
      "source": 108,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "64ea9b0659b22f80b68b27860339e77e",
      "line": 179,
      "relation": "positiveCorrelation",
      "source": 95,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "c675ddb9ee02179812af94d3d272590d",
      "line": 180,
      "relation": "positiveCorrelation",
      "source": 96,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "9f839609247d6f85d0e29b019dfe6010",
      "line": 181,
      "relation": "positiveCorrelation",
      "source": 94,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Poorkaj et al. reported two exonic mutations (P301L and V337M) in two families with FTDP-17 [139], while Hutton et al. reported six different mutations in 10 families: three of these mutations (G272V, P301L and R406W) were missense mutations in exons, while the other three were in the 5' splice site of exon 10 [140].",
      "key": "40b48c1f08cf54bab5a0c09074cd050c",
      "line": 182,
      "relation": "positiveCorrelation",
      "source": 92,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "601e9930d8a5cab347863998840b9ee1",
      "line": 190,
      "relation": "positiveCorrelation",
      "source": 100,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "c4c10f9c1274f85299f2508572faf5ee",
      "line": 191,
      "relation": "positiveCorrelation",
      "source": 100,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "4614710a667a461d55c0da51a7f23333",
      "line": 192,
      "relation": "causesNoChange",
      "source": 100,
      "target": 0
    },
    {
      "key": "43f8aa2a11a17d4bd451e7e21957def2",
      "relation": "hasVariant",
      "source": 99,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "08b8c5d6bbe1c18b1721b33c48ad15e1",
      "line": 194,
      "relation": "association",
      "source": 44,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "cf210cb2e9bc3e63e886f0b2a4204d56",
      "line": 194,
      "relation": "association",
      "source": 109,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "ed24b30244ea2c089fd7213f6bf9f0be",
      "line": 195,
      "relation": "association",
      "source": 109,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",
      "key": "cf48d137acc240694098218e13208062",
      "line": 195,
      "relation": "association",
      "source": 43,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The tau fragment first isolated from the PHF core is approximately 100 amino acids in length. Its N-terminus was defined by sequence analysis [30,56], and its C-terminus was defined by epitope mapping of MN423. Immunoreactivity was shown to depend on a specific C-terminal trunctation at Glu391 [33,150].",
      "key": "0f713ff614a264a0adcfbd6a9dae836e",
      "line": 202,
      "relation": "association",
      "source": 93,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The tau fragment first isolated from the PHF core is approximately 100 amino acids in length. Its N-terminus was defined by sequence analysis [30,56], and its C-terminus was defined by epitope mapping of MN423. Immunoreactivity was shown to depend on a specific C-terminal trunctation at Glu391 [33,150].",
      "key": "199a99119c91ec24ca8cb9dc8c07c643",
      "line": 202,
      "relation": "association",
      "source": 50,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The tau fragment first isolated from the PHF core is approximately 100 amino acids in length. Its N-terminus was defined by sequence analysis [30,56], and its C-terminus was defined by epitope mapping of MN423. Immunoreactivity was shown to depend on a specific C-terminal trunctation at Glu391 [33,150].",
      "key": "ff3530285042835f22d1f5bc674a546e",
      "line": 203,
      "relation": "partOf",
      "source": 50,
      "target": 28
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage III": true,
          "Stage VI": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In a prospective study three different synaptic protein (synaptophysin, SNAP-25 and syntaxin) were found to be progressively decreased in neocortex at Braak stages III-VI [158], NFT-bearing neurons demonstrating, for example, a 35%–57% reduction in synaptophysin mRNA in AD brain [159].",
      "key": "39348ff2988b55f501c0b36f84fbd3e9",
      "line": 212,
      "relation": "negativeCorrelation",
      "source": 28,
      "target": 111
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage III": true,
          "Stage VI": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In a prospective study three different synaptic protein (synaptophysin, SNAP-25 and syntaxin) were found to be progressively decreased in neocortex at Braak stages III-VI [158], NFT-bearing neurons demonstrating, for example, a 35%–57% reduction in synaptophysin mRNA in AD brain [159].",
      "key": "ea9bec3a37d3df55aed53398cc83b80e",
      "line": 213,
      "relation": "negativeCorrelation",
      "source": 28,
      "target": 101
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage III": true,
          "Stage VI": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In a prospective study three different synaptic protein (synaptophysin, SNAP-25 and syntaxin) were found to be progressively decreased in neocortex at Braak stages III-VI [158], NFT-bearing neurons demonstrating, for example, a 35%–57% reduction in synaptophysin mRNA in AD brain [159].",
      "key": "8ffe55d0f32ebbb169841d8361072ba4",
      "line": 214,
      "relation": "negativeCorrelation",
      "source": 28,
      "target": 103
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage III": true,
          "Stage VI": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In a prospective study three different synaptic protein (synaptophysin, SNAP-25 and syntaxin) were found to be progressively decreased in neocortex at Braak stages III-VI [158], NFT-bearing neurons demonstrating, for example, a 35%–57% reduction in synaptophysin mRNA in AD brain [159].",
      "key": "96795458eb6d97332cf651f8f261cb6f",
      "line": 212,
      "relation": "negativeCorrelation",
      "source": 111,
      "target": 28
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage III": true,
          "Stage VI": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In a prospective study three different synaptic protein (synaptophysin, SNAP-25 and syntaxin) were found to be progressively decreased in neocortex at Braak stages III-VI [158], NFT-bearing neurons demonstrating, for example, a 35%–57% reduction in synaptophysin mRNA in AD brain [159].",
      "key": "d0ed382daa3fa97deabd58ed183ce7da",
      "line": 213,
      "relation": "negativeCorrelation",
      "source": 101,
      "target": 28
    },
    {
      "annotations": {
        "Braak_Stage": {
          "Stage III": true,
          "Stage VI": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In a prospective study three different synaptic protein (synaptophysin, SNAP-25 and syntaxin) were found to be progressively decreased in neocortex at Braak stages III-VI [158], NFT-bearing neurons demonstrating, for example, a 35%–57% reduction in synaptophysin mRNA in AD brain [159].",
      "key": "2b9ab183de4317be707b896eedd8be62",
      "line": 214,
      "relation": "negativeCorrelation",
      "source": 103,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The most recent data obtained indicate that tau pathology indeed may be induced and propagated after the injection of tau oligomers or aggregates in either wild-type or mutated MAPT transgenic mice [164], and that tau aggregates can be transferred from cell to cell in vitro [164,165] and in vivo [166,167].",
      "key": "bff69eecbd6cf5bf43cbacceceddfdaf",
      "line": 223,
      "relation": "positiveCorrelation",
      "source": 22,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "The most recent data obtained indicate that tau pathology indeed may be induced and propagated after the injection of tau oligomers or aggregates in either wild-type or mutated MAPT transgenic mice [164], and that tau aggregates can be transferred from cell to cell in vitro [164,165] and in vivo [166,167].",
      "key": "58c872fe3629dd731e820ea4b70e9647",
      "line": 223,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "positiveCorrelation",
      "source": 22,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "faf6dce9c527c7160a500cdc9d611f57",
      "line": 232,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "a2663f276dddbebe0b49a2eadde07610",
      "line": 240,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "isA",
      "source": 31,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Matrix": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "46eba9c9a1a3619f0a997a2e3021db25",
      "line": 234,
      "relation": "association",
      "source": 47,
      "target": 10
    },
    {
      "key": "52be6a6d9abc56c6b7743856fb04df6c",
      "relation": "partOf",
      "source": 47,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Matrix": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "7b9160439337b302be619c46de2e98fc",
      "line": 235,
      "relation": "increases",
      "source": 47,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Matrix": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "67bdc01728e46601a5d75e951f963f86",
      "line": 234,
      "relation": "association",
      "source": 10,
      "target": 47
    },
    {
      "key": "0958b058edd294fadaa2c7342139b0ca",
      "relation": "partOf",
      "source": 10,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "aff98673010f269331cc2b7fe89a80c8",
      "line": 237,
      "relation": "positiveCorrelation",
      "source": 41,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "543971dd384f5c7245377dd3358ad728",
      "line": 237,
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "def37bb7ecbfd500880101e2bcf84dc2",
      "line": 239,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "isA",
      "source": 38,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "2a1b1e38cd1219c2cdeef91694867c00",
      "line": 241,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "isA",
      "source": 30,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "In the case of soluble monomeric or small oligomeric tau protein, the endocytosis appears to be clathrin-dependent (reviewed in [169]). In contrast, larger aggregates of tau could bind heparin in the extracellular matrix and be internalized through macropinocytosis [170]. As a result of exocytosis and endocytosis, the spreading of tau can occur in various neurodegenerative diseases (tauopathies) including AD. Three plausible mechanisms of tau spreading are shown schematically in Figure 6. Additionally, it appears that microglial cells may facilitate tau propagation by phagocytosis and exocytosis of tau protein [171].",
      "key": "971a8d85cf89c55faac5d875f94d2084",
      "line": 242,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Neurons",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 21,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Green coffee, a non-toxic small molecule, found to be an inhibitor of protein phosphatase 2A methylesterase, was shown to improve cognitive and motor performance in mouse models with tau pathology",
      "key": "fabfc994f5fee21747a93a17548191ed",
      "line": 248,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Green coffee, a non-toxic small molecule, found to be an inhibitor of protein phosphatase 2A methylesterase, was shown to improve cognitive and motor performance in mouse models with tau pathology",
      "key": "5fbeb2778f47a95e4ef545b512ca094b",
      "line": 249,
      "relation": "increases",
      "source": 5,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Green coffee, a non-toxic small molecule, found to be an inhibitor of protein phosphatase 2A methylesterase, was shown to improve cognitive and motor performance in mouse models with tau pathology",
      "key": "ff2d617bba5e2babea6340e5fc00688a",
      "line": 250,
      "relation": "increases",
      "source": 5,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A quite different strategy is to target tau clearance—e.g., by rapamycin that induces macroautophagy [175], inhibitors of Hsp90 chaperone protein that binds to misfolded proteins or by immunotherapeutic approaches [176].",
      "key": "025f5132112af2228cb909a30cfcf91a",
      "line": 257,
      "relation": "increases",
      "source": 17,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A quite different strategy is to target tau clearance—e.g., by rapamycin that induces macroautophagy [175], inhibitors of Hsp90 chaperone protein that binds to misfolded proteins or by immunotherapeutic approaches [176].",
      "key": "74ec4b4cffd68c645896fd6cd2bc45ba",
      "line": 258,
      "relation": "decreases",
      "source": 37,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "A quite different strategy is to target tau clearance—e.g., by rapamycin that induces macroautophagy [175], inhibitors of Hsp90 chaperone protein that binds to misfolded proteins or by immunotherapeutic approaches [176].",
      "key": "218ba0b4b20e77debdaffb34453ab8a9",
      "line": 261,
      "relation": "decreases",
      "source": 48,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB is a phenothiazine that crosses the blood brain barrier and acts as a redox cycler. Moreover, besides its beneficial properties as being able to improve energy metabolism and to act as an antioxidant, it is also able to reduce tau protein aggregation",
      "key": "fe3bb6db4ee07f98690227d1bf73bd1a",
      "line": 268,
      "relation": "decreases",
      "source": 3,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "2d9a762ec73e26dd761269c8415035c8",
      "line": 274,
      "relation": "increases",
      "source": 3,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "a33bd7299d90d784fb0f4bd01c013417",
      "line": 275,
      "relation": "association",
      "source": 3,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "28ad5f52e910dc41b777a87af295aa86",
      "line": 280,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "74df77481c90ddde33be00f4fdad32e2",
      "line": 281,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "260c3adc49227bc5e1101dd811accca4",
      "line": 275,
      "relation": "association",
      "source": 34,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "6500deff75bb749d9ff1b8e567e987fc",
      "line": 277,
      "relation": "association",
      "source": 34,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "c7c5e016198b9b0601d02724040b5cd4",
      "line": 279,
      "relation": "association",
      "source": 34,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "8d476f993404dc658a0372d296a5c20f",
      "line": 276,
      "relation": "increases",
      "source": 1,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "b0c48c0eb686bac4b33e507a37ac9ab0",
      "line": 277,
      "relation": "association",
      "source": 1,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "ea312adc3c5af19dda0fdb10ef12f6cf",
      "line": 282,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 1,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "e5141c832f6731e05fdcee0cd8de0d85",
      "line": 283,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 1,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "ba7cf2d71bd76563cad21332b93b4fca",
      "line": 278,
      "relation": "increases",
      "source": 2,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "90fd2ff0f2baabde18ae34ba2529d6fe",
      "line": 279,
      "relation": "association",
      "source": 2,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "0e4eceb34fee43050dfdff147dc4b904",
      "line": 284,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "MB, together with its derivatives (metabolites), azure A and azure B, is able to stimulate protein degradation and inhibit oxidative damage [184] and also inhibit the activity of caspase-1 and caspase-3 [185].",
      "key": "c8fee5444d6a1dfbef23cb88c3c880f4",
      "line": 285,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Recently, it has been proposed that tau protein acetylation may be responsible for tau aggregation in AD. Grinberg and collaborators detected tau acetylation at Lys274 in all tauopathies (both primary and secondary), except in AgD",
      "key": "00cb15f3efaba988e93238d3c5b8cb66",
      "line": 292,
      "relation": "increases",
      "source": 63,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "6d6fd71341a8ee3b1343b8d58e9dbf7d",
      "line": 300,
      "relation": "decreases",
      "source": 16,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "36b4fbff511adebc62f7bf73466c322d",
      "line": 301,
      "relation": "decreases",
      "source": 26,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "3150ba9a9946fb8cccc3f731b91eee95",
      "line": 302,
      "relation": "decreases",
      "source": 24,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "e638a848b98d66b57e576a78b71186a9",
      "line": 303,
      "relation": "decreases",
      "source": 27,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "51278103978c6675946ed391cb6d833f",
      "line": 305,
      "relation": "decreases",
      "source": 18,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "eaf16bcbe0d894e238f1241ed455849f",
      "line": 306,
      "relation": "decreases",
      "source": 25,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "e991321f8037f6073839ee3ab3800b0e",
      "line": 307,
      "relation": "decreases",
      "source": 12,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "d809de3bb73f53e6793c206a1e002504",
      "line": 308,
      "relation": "decreases",
      "source": 6,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "bb705aca10f6cb67d0158c397c7143aa",
      "line": 309,
      "relation": "decreases",
      "source": 11,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "f777ece618127cad7013d06a68dd4987",
      "line": 310,
      "relation": "decreases",
      "source": 23,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "eb4b99b94dc6073f30a6cb6cd028944f",
      "line": 312,
      "relation": "decreases",
      "source": 13,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "050fde5b4b963287bd798762d4f24ff3",
      "line": 314,
      "relation": "decreases",
      "source": 9,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "4df10f21f679e5193722f750e1f9ae87",
      "line": 315,
      "relation": "decreases",
      "source": 7,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "30ac380e57802196200eeb82bd0eea6b",
      "line": 316,
      "relation": "decreases",
      "source": 8,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Babić Leko M",
          "Bažadona D",
          "Buée L",
          "Delalle I",
          "Di Giovanni G",
          "Harrington C",
          "Hof PR",
          "Jovanov-Milošević N",
          "Wischik C",
          "Wray S",
          "de Silva R",
          "Šimić G"
        ],
        "date": "2016-01-06",
        "db": "PubMed",
        "db_id": "26751493",
        "db_name": "Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.",
        "first": "Šimić G",
        "journal": "Biomolecules",
        "last": "Hof PR",
        "pages": "6",
        "volume": "6"
      },
      "evidence": "Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones",
      "key": "f10c4dfaa685e2c501bee23436e9c7d7",
      "line": 317,
      "relation": "decreases",
      "source": 15,
      "target": 47
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"azure A\")",
      "concept": {
        "name": "azure A",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "298c94c7a293e61cac464dd08c470dc1"
    },
    {
      "bel": "a(CHEBI:\"azure B\")",
      "concept": {
        "name": "azure B",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "26a33036244ec62a77c1297b35253fa1"
    },
    {
      "bel": "a(CHEBI:\"methylene blue\")",
      "concept": {
        "name": "methylene blue",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7beb4cf796511846dabed14b6118ee48"
    },
    {
      "bel": "a(CHEBI:\"phosphatidylinositol bisphosphate\")",
      "concept": {
        "name": "phosphatidylinositol bisphosphate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9d8fc562d44e185dfd9b55ebd1f639cf"
    },
    {
      "bel": "a(CHEBI:\"trans-5-O-caffeoyl-D-quinic acid\")",
      "concept": {
        "name": "trans-5-O-caffeoyl-D-quinic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "2c5916546efe66bc9a6b458477569d45"
    },
    {
      "bel": "a(CHEBI:Iproniazid)",
      "concept": {
        "name": "Iproniazid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "3d84c63411d5514b811a3903e54fe289"
    },
    {
      "bel": "a(CHEBI:daunorubicin)",
      "concept": {
        "name": "daunorubicin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "eb2a262156730cbbd2afab116cd4e78c"
    },
    {
      "bel": "a(CHEBI:doxorubicin)",
      "concept": {
        "name": "doxorubicin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "36b81fc3df19f2c9d3490d3fce5232c9"
    },
    {
      "bel": "a(CHEBI:emodin)",
      "concept": {
        "name": "emodin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4d7bb52514445ca01fd210aa7025359d"
    },
    {
      "bel": "a(CHEBI:heparin)",
      "concept": {
        "name": "heparin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ce9c9ee733209cd7a8b905cec98ea0d6"
    },
    {
      "bel": "a(CHEBI:iproclozide)",
      "concept": {
        "name": "iproclozide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a2705d8f0e380732586047185ab62725"
    },
    {
      "bel": "a(CHEBI:isoniazide)",
      "concept": {
        "name": "isoniazide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8e913ad87e22ddd646941ffec8c2e3d2"
    },
    {
      "bel": "a(CHEBI:myricetin)",
      "concept": {
        "name": "myricetin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f6748824a85183b0d19634f11372b9f1"
    },
    {
      "bel": "a(CHEBI:phosphatidylinositol)",
      "concept": {
        "name": "phosphatidylinositol",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "dc41646e25dfac30af768483b61d9783"
    },
    {
      "bel": "a(CHEBI:quinalizarin)",
      "concept": {
        "name": "quinalizarin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ca05e8f188f4929d7e6ec20c1f02e79f"
    },
    {
      "bel": "a(CHEBI:rhodanine)",
      "concept": {
        "name": "rhodanine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "d000af83acc970fbf7e53745921ab16f"
    },
    {
      "bel": "a(CHEBI:sirolimus)",
      "concept": {
        "name": "sirolimus",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "561f7408129243e1ed091f506ef0dded"
    },
    {
      "bel": "a(CHEBI:thiostrepton)",
      "concept": {
        "name": "thiostrepton",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8fbbe5c0d750961d3f680115f82cf488"
    },
    {
      "bel": "a(CL:0000127)",
      "concept": {
        "name": "0000127",
        "namespace": "CL"
      },
      "function": "Abundance",
      "id": "b82761d2c58be0c04284874615f0584b"
    },
    {
      "bel": "a(CL:0000128)",
      "concept": {
        "name": "0000128",
        "namespace": "CL"
      },
      "function": "Abundance",
      "id": "3df5da42be59eabe6d4cdd53b9fad21f"
    },
    {
      "bel": "a(CL:0000129)",
      "concept": {
        "name": "0000129",
        "namespace": "CL"
      },
      "function": "Abundance",
      "id": "37ebc5491bfcc36b1b75ed2f752446fe"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "8e1da50e6008ffdd1b37825776666311"
    },
    {
      "bel": "a(CONSO:isocarboxazide)",
      "concept": {
        "name": "isocarboxazide",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "b49b72566daa01a2739301ba8c027961"
    },
    {
      "bel": "a(CONSO:oxazolidinedione)",
      "concept": {
        "name": "oxazolidinedione",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "f2305dae8362bddb8c2a39062180fd10"
    },
    {
      "bel": "a(CONSO:sudoxicam)",
      "concept": {
        "name": "sudoxicam",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "d6cbcb40bc843ea2406d066a40bd8c20"
    },
    {
      "bel": "a(CONSO:thiohydantoin)",
      "concept": {
        "name": "thiohydantoin",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "2b7abeece700aec3120db198c980df9b"
    },
    {
      "bel": "a(CONSO:thioxooxazolidine)",
      "concept": {
        "name": "thioxooxazolidine",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "220bd9b2d8ba861d03e5b06c1a9ce9f3"
    },
    {
      "bel": "a(GO:\"neurofibrillary tangle\")",
      "concept": {
        "name": "neurofibrillary tangle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "274b01539a0746fbee06884b2af6c533"
    },
    {
      "bel": "a(MESH:\"Receptors, N-Methyl-D-Aspartate\")",
      "concept": {
        "name": "Receptors, N-Methyl-D-Aspartate",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9243c01ac01a47ab2b889a759940325e"
    },
    {
      "bel": "bp(GO:\"cell-cell signaling via exosome\")",
      "concept": {
        "name": "cell-cell signaling via exosome",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b51e4ad588d1d39c133eac1f412ea4ca"
    },
    {
      "bel": "bp(GO:\"clathrin-dependent endocytosis\")",
      "concept": {
        "name": "clathrin-dependent endocytosis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "27f8cb71329fa31a19d34b3b9b3c8b67"
    },
    {
      "bel": "bp(GO:\"motor behavior\")",
      "concept": {
        "name": "motor behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a2dcc4ec00ebc4321e0089baccd16aa5"
    },
    {
      "bel": "bp(GO:\"protein catabolic process\")",
      "concept": {
        "name": "protein catabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b670adb6c51d1078c8508e861db111a1"
    },
    {
      "bel": "bp(GO:\"response to oxidative stress\")",
      "concept": {
        "name": "response to oxidative stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d501b05a4babb0401c86b84d8abf2db7"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(GO:macroautophagy)",
      "concept": {
        "name": "macroautophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3729ed11227ec2e1ef3f2bce5cc7b6d3"
    },
    {
      "bel": "bp(GO:macropinocytosis)",
      "concept": {
        "name": "macropinocytosis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f8b4dc0df6ea2dc25bcba995781d363f"
    },
    {
      "bel": "bp(MESH:\"Transcription, Genetic\")",
      "concept": {
        "name": "Transcription, Genetic",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "ad688844f89f05094cdeb0c1a4f2a7b4"
    },
    {
      "bel": "complex(GO:\"proteasome complex\")",
      "concept": {
        "name": "proteasome complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "60eac9a2a13b2c4ebafe4ec275b444a2"
    },
    {
      "bel": "complex(a(CHEBI:heparin), p(CONSO:\"Tau aggregates\"))",
      "function": "Complex",
      "id": "f1a376f2da7f9999a86daa4cdf42ddce",
      "members": [
        {
          "bel": "a(CHEBI:heparin)",
          "concept": {
            "name": "heparin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "ce9c9ee733209cd7a8b905cec98ea0d6"
        },
        {
          "bel": "p(CONSO:\"Tau aggregates\")",
          "concept": {
            "name": "Tau aggregates",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "d03adc6b1e424e742ba646d63a61f48e"
        }
      ]
    },
    {
      "bel": "g(CONSO:\"APOE e3\")",
      "concept": {
        "name": "APOE e3",
        "namespace": "CONSO"
      },
      "function": "Gene",
      "id": "63084ec055edd4bb4277ca3aa0abc109"
    },
    {
      "bel": "g(DBSNP:rs242557)",
      "concept": {
        "name": "rs242557",
        "namespace": "DBSNP"
      },
      "function": "Gene",
      "id": "b9ba1edb64087801cbba953ccfef0d8e"
    },
    {
      "bel": "g(DBSNP:rs2471738)",
      "concept": {
        "name": "rs2471738",
        "namespace": "DBSNP"
      },
      "function": "Gene",
      "id": "14b5fad935aa9730b5bc8a221d6e71ac"
    },
    {
      "bel": "p(CONSO:\"3R tau\")",
      "concept": {
        "name": "3R tau",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "246e602cb53558e945b03407c219c5e1"
    },
    {
      "bel": "p(CONSO:\"4R tau\")",
      "concept": {
        "name": "4R tau",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "c5fd156b7c1a309ed11b8dca3e247657"
    },
    {
      "bel": "p(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "d03adc6b1e424e742ba646d63a61f48e"
    },
    {
      "bel": "p(CONSO:\"Tau antibody, RG7345\")",
      "concept": {
        "name": "Tau antibody, RG7345",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "5ba380f902f26c6d9f8db5c68000e2a5"
    },
    {
      "bel": "p(CONSO:\"microtubule-binding region\")",
      "concept": {
        "name": "microtubule-binding region",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "a37bfc324c697c5840d8d099152b779c"
    },
    {
      "bel": "p(CONSO:\"paired helical filaments\")",
      "concept": {
        "name": "paired helical filaments",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "0bb08a6e59ca5c7490738810a0985e9f"
    },
    {
      "bel": "p(CONSO:\"projection domain\")",
      "concept": {
        "name": "projection domain",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "430f30e2900149f62a53b91bbdc1789d"
    },
    {
      "bel": "p(CONSO:\"tubulin-binding repeat 1\")",
      "concept": {
        "name": "tubulin-binding repeat 1",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "84b253775b2fb769f4660f4d4a91444b"
    },
    {
      "bel": "p(FPLX:PLC)",
      "concept": {
        "name": "PLC",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "cb856431c936692cd244fd2aae545fed"
    },
    {
      "bel": "p(HGNC:CASP1)",
      "concept": {
        "name": "CASP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "757e8982730dda44190069437655a3cf"
    },
    {
      "bel": "p(HGNC:CASP3)",
      "concept": {
        "name": "CASP3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bdb963bb3852568b08002cd7bd9187b1"
    },
    {
      "bel": "p(HGNC:DLG4)",
      "concept": {
        "name": "DLG4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "082b74394486030c137352b1d3f26b92"
    },
    {
      "bel": "p(HGNC:FGR)",
      "concept": {
        "name": "FGR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7a9a050032dc75825e9900dff50c8bd1"
    },
    {
      "bel": "p(HGNC:FYN)",
      "concept": {
        "name": "FYN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9aaa70667f9bfd5fd59c45422ea4c02c"
    },
    {
      "bel": "p(HGNC:GRB2)",
      "concept": {
        "name": "GRB2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dac7b04df04d8a0bac1269d3918d2179"
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "concept": {
        "name": "HDAC6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8f10ead99d8970092c3980eb37bcfb3a"
    },
    {
      "bel": "p(HGNC:LCK)",
      "concept": {
        "name": "LCK",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b12ffdabce4924617b183ab3df9c996f"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ac, Lys, 274))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bf50e603fa44b44815f1e26edda4d0e0",
      "variants": [
        {
          "code": "Lys",
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 274
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 113))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5efbf806e62b74352a277e12ab43c70b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 113
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 185))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fadeb5537304a15236ed0fa502da972a",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 185
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 191))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a0ba1bc586070cc64f85e8992b2fb967",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 191
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 208))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a48f2c71f5fd28086879e747a7b84043",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 208
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 210))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e7080f7d45243b2f5375af77806a29bf",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 210
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 214))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "db0314eacd12a1283c87a6e94b8058a7",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 214
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 237))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f28e33ff835a843cab4244877d6ccb87",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 237
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 238))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "189f946b46fe45975d712c073846a8a0",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 238
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 258))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "91fc74a659a3b9375914610483bda022",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 258
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 262))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "06b0d7203a7f93cbb663eab8b9b593ab",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 262
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 289))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "49da3469dc2f48b03ed37f093bb68059",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 289
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 356))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5eb6d95220e92f14e6fd76a31f51dcd4",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 356
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 409))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "023c5a48bee1871d0f53c2823c7c700b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 409
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 422))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "393be594a81d2f0c5386c424aa4cc22b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 422
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 433))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c63acdce105f7b9c7064d79fffbe2dc1",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 433
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 435))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e17f76f3cad65d09a8db0f2dd153d8ce",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 435
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 68))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d35c3e4f035e02467652f582ba439ca6",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 68
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 123))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2a926bb921cbdde7e7cfbbe619e12d35",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 123
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 153))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1f6a427515fbea880c470ac805e0045a",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 153
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 175))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3c5d3e531de3ebae1334e0ca554751c2",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 175
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 184))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "424a8da9f0cd42854d9a36abc6cdf9d2",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 184
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 403))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "14c1c04f8c68145ab017637e6208a410",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 403
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 427))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "edf44f18f6d5b630a2e23993dc00627e",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 427
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 69))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f92b13bc6f35322d58a366a1d3220e9d",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 69
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 71))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9fefff664f366bb9bbcab4f55347bdd4",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 71
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Tyr, 18))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "35af0eb95b9cfff2cdc864c20f5624f9",
      "variants": [
        {
          "code": "Tyr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 18
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Tyr, 197))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2f72df34d181e492fad022bf886b3f1d",
      "variants": [
        {
          "code": "Tyr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 197
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Tyr, 394))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5b85ae4854552bbff5be2955060d909f",
      "variants": [
        {
          "code": "Tyr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 394
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"p.Arg406Trp\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7a806f2b82baa7567669a0514b54d74a",
      "variants": [
        {
          "hgvs": "p.Arg406Trp",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"p.Glu391*\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6b9894789d5789eb3792ec5e3ed489a6",
      "variants": [
        {
          "hgvs": "p.Glu391*",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"p.Gly272Val\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "83d665c25d74e7c30979327dcb5938c8",
      "variants": [
        {
          "hgvs": "p.Gly272Val",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"p.Pro301Leu\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ba35d8874023cf0115d435afc490b61b",
      "variants": [
        {
          "hgvs": "p.Pro301Leu",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"p.Val337Met\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "845eebd997d9a764501da70bf7cd69e5",
      "variants": [
        {
          "hgvs": "p.Val337Met",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PIN1)",
      "concept": {
        "name": "PIN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "24383f5cd8a14dfb9bb692e0fb5f9d7b"
    },
    {
      "bel": "p(HGNC:PPME1)",
      "concept": {
        "name": "PPME1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6502fa3f17eeb6dd2b60a50105fa17b9"
    },
    {
      "bel": "p(HGNC:PSEN1)",
      "concept": {
        "name": "PSEN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "718dad5063fc52f019ce7aaa43183908"
    },
    {
      "bel": "p(HGNC:PSEN1, var(\"p.Gly183Val\"))",
      "concept": {
        "name": "PSEN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "64dbd00de0ac59da3b82545cc6728c45",
      "variants": [
        {
          "hgvs": "p.Gly183Val",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNAP25)",
      "concept": {
        "name": "SNAP25",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4052512ffae233782098caaa50e47b65"
    },
    {
      "bel": "p(HGNC:SRC)",
      "concept": {
        "name": "SRC",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5bbd95ea1b6e2166887017af0837608d"
    },
    {
      "bel": "p(PFAM:Syntaxin)",
      "concept": {
        "name": "Syntaxin",
        "namespace": "PFAM"
      },
      "function": "Protein",
      "id": "4e9bb900f946179606e663138d57b556"
    },
    {
      "bel": "path(CONSO:\"Argyrophilic Grain Disease\")",
      "concept": {
        "name": "Argyrophilic Grain Disease",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "320e6a9e7887bb4921cd83e79880d0c9"
    },
    {
      "bel": "path(CONSO:\"Corticobasal Degeneration\")",
      "concept": {
        "name": "Corticobasal Degeneration",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "ec09f7088662ad7a6fc4255383110794"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "concept": {
        "name": "Frontotemporal Dementia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "876d8dfbadfb211122e2ba889d763c19"
    },
    {
      "bel": "path(MESH:\"Niemann-Pick Diseases\")",
      "concept": {
        "name": "Niemann-Pick Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "dc39677fa0ec2756cd602da493bf7227"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "concept": {
        "name": "Parkinson Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e45482025720b7db29c4fea458b4cae9"
    },
    {
      "bel": "path(MESH:\"Supranuclear Palsy, Progressive\")",
      "concept": {
        "name": "Supranuclear Palsy, Progressive",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e020e57c09a4c1910b18ec35c70e598f"
    },
    {
      "bel": "r(HGNC:SYP)",
      "concept": {
        "name": "SYP",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "e9c59054dd92090e1db697997aeddf0f"
    },
    {
      "bel": "r(MGI:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "RNA",
      "id": "c49e3abf1f2671195b22bfa40ed94e33"
    }
  ]
}